Announcements

4 July 2025
MDPI’s Newly Launched Journals in June 2025

Six new journals covering a range of subjects launched their inaugural issues in June 2025. We are excited to be able to share with you the newest research rooted in the value of open access. We are pleased to present the latest research and to make it accessible to all.

We extend our sincere thanks to all the Editorial Board Members for their commitment and expertise. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal Topics (Selected)
Prof. Dr. Chang-Pu Sun,
China Academy of Engineering Physics, Beijing, China; Computational Science Research Center, China
Editorial | View inaugural issue
quantum information and phenomena; condensed matter physics and statistical physics; atomic, molecular, and optical physics; computational physics and mathematical methods
View journal scope | Submit an article
Prof. Dr. Hualiang Lin,
Sun Yat-sen University, China;
Prof. Dr. Jose L. Domingo,
Universitat Rovira i Virgili, Spain
Editorial | View inaugural issue
green and organic food; green infrastructures; green exercise; environmental impact of the healthcare sector; effects of climate change on human health |
View journal scope | Submit an article
Prof. Dr. Francesco Veglio,
University of L’Aquila, Italy
Editorial | View inaugural issue
ultra-pure substances; water purification; air purification; gas purification; inorganic chemical purification; purification technologies
View journal scope | Submit an article
Prof. Dr. Junxing Zheng,
Huazhong University of Science and Technology, China
Editorial | View inaugural issue
computer-aided design and engineering; artificial intelligence and machine learning; building information modeling (BIM) and digital twins; robotics and automation in construction; smart sensors and Internet of Things (IoT); intelligent control systems and facilities management
View journal scope | Submit an article
Prof. Dr. Assunta Di Vaio,
University of Naples Parthenope, Italy
Editorial | View inaugural issue
sustainability, managerial, and biodiversity accounting; carbon management accounting; corporate social responsibility; artificial intelligence and disclosure
View journal scope | Submit an article
Prof. Dr. Changjun Liu,
Sichuan University, China
Editorial | View inaugural issue
bioeffects of electromagnetic waves; electromagnetic science and engineering; microwave, millimeter-wave, and terahertz technologies; metamaterials and metasurfaces; communication, sensing, and networks; energy, power, and sustainable applications; quantum and emerging technologies; artificial intelligence and advanced fabrication
View journal scope | Submit an article
We wish to thank everyone who has supported the development of open access publishing. If you are interested in launching a new open access journal with us, you are welcome to send an application here.

2 July 2025
MDPI INSIGHTS: The CEO's Letter #24 - 2024 Impact Factor & CiteScore, MDPI Summits France & USA, Tu Youyou Award

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI’s 2024 Impact Factor Highlights

For those of our readers who are new to academic publishing, you may have heard some news in June around the Impact Factor release. Every year, typically in June, Clarivate releases its annual Journal Citation Reports (JCR), which include Journal Impact Factors (JIF). This metric is widely used in academic publishing to reflect the average number of citations received by recent articles in each journal.

While Impact Factor is just one of many indicators of journal influence, it remains a major milestone for authors, editors, and publishers. It’s used to assess journal visibility, researcher recognition, and scholarly reach. Throughout our international meetings and events, it’s clear that the Impact Factor is something many of our authors and editorial board members care about, as it can influence where they choose to submit an article and the funding they receive for their research.

“These results reflect the trust that the scholarly community places in MDPI”

MDPI’s 2024 Impact Factor Highlights

  • 298 MDPI journals received a Journal Impact Factor.
  • 60 journals earned their first-ever Impact Factor
    • To put this in perspective: MDPI’s 60 new journal acceptances into the Web of Science was the second highest number of any publisher in 2024, behind Elsevier and ahead of Springer Nature. Our 87% acceptance rate for journals submitted to Web of Science shows the strength of our editorial process and our proven ability to develop journals aligned with Clarivate’s 24 evaluation criteria.
    • Notably, Textiles, Mathematics, International Journal of Neonatal Screening, Smart Cities, Systems, and Pharmaceutics ranked in the top 10% in their respective categories, highlighting their growing influence and prestige within their academic fields. This shows that high-quality indexing goes beyond visibility; it upholds credibility and trust.
  • 193 MDPI journals are now ranked in the top 50% (Q1/Q2) of their subject categories.
    • What does this mean, and why is it important? Journals are ranked by quartiles within their field, based on their Impact Factor. Q1 represents the top 25% of journals in their category, Q2 the next 25%, and so on. Being in Q1 or Q2 shows that a journal is performing well relative to other journals in its category. Authors and institutions often look at quartile rankings when choosing where to publish – it’s an important indicator of visibility and recognition, within its respective category.
  • 116 of our previously ranked journals increased their Impact Factor.
  • 14 MDPI journals achieved an Impact Factor of 5.0 or higher, suggesting a high degree of influence and visibility.

These results reflect our staff's hard work: from our editorial and production teams to our indexing, communications, and data teams, and beyond. This also reflects the trust that the scholarly community places in MDPI, reinforcing the message that when researchers publish with MDPI, they publish with impact.

Open Access with Impact

As the leading fully open access publisher, our journals have received a total of 18.4 million citations in the Web of Science by the end of 2024, reflecting the growing reach and engagement of research published with MDPI. We are committed to making scientific research freely accessible to everyone, everywhere. With the support of more than 4.2 million contributing authors, we’re proud to support the global shift toward open access.

Further Reading

If you’d like to better understand how journals get indexed and why Impact Factors matter, please read this recent interview with Dr. Constanze Schelhorn (Head of Indexing). It gives you a behind-the-scenes look at the role our indexing team plays in supporting journal indexing and visibility.

You can also read our official news announcement shared last week: MDPI Journals in the 2024 Journal Citation Reports.

Thank you to everyone, from our authors and reviewers to our editors and internal teams, who contributed to the progress of our journal indexing in 2024. We’re continuing to build journals that are recognized and trusted across disciplines.

Impactful Research

MDPI Journals See Continued Growth in 2024 CiteScore Results

Continuing our indexing updates, I’m pleased to share that MDPI has achieved strong results in the latest CiteScore metrics, released on 5 June by Scopus. These results reflect the collective efforts of our editors, reviewers, authors, and internal teams, with their dedication to quality and visibility in scientific publishing. You can read the full announcement here.

2024 Highlights:

  • 322 MDPI journals received a CiteScore (up from 274 last year).
  • 283 journals (88%) are ranked in Q1 or Q2 of their subject categories.
  • 237 journals (85%) saw an increase in their CiteScore compared to last year.
  • 48 journals received a CiteScore for the first time.
  • 39 journals are now placed in the top 10% of their subject areas.

“This growth highlights our commitment to supporting open, trusted science”

What is CiteScore and how is it measured?

CiteScore metrics are developed by Elsevier as an alternative to the Impact Factor. They measure the citation impact of journals and can be accessed freely on Scopus. The metric represents the yearly average number of citations to recent articles published in a journal. If you’re interested in learning more about citation metrics and how we use them, check out this blog post.

Why is this important?

These results show the growing recognition for, and impact of, MDPI journals across disciplines. CiteScore rankings help researchers, institutions, and funders assess where high-quality work is being published. This growth improves our journals’ positioning in the publishing landscape and highlights our commitment to supporting open, trusted science.

Inside MDPI

Highlights from the MDPI USA Summit in Boston (5–6 June)

With several Summits already behind us, I think this is a good time to reflect on the purpose of these Summits.

Why do we organize MDPI Summits?

These one-and-a-half-day, invite-only gatherings are designed to improve our relationships with Chief Editors who lead our journals and are respected voices in their fields. The Summits aim to:

  1. Share MDPI’s values, achievements, editorial practices, and local market collaborations.
  2. Collect feedback on MDPI operations and journal practices.
  3. Empower Chief Editors to confidently represent MDPI beyond the Summit.

While Chief Editors know their journals well, these events help them better understand MDPI. We want them to be ambassadors for our brand. The aim is for them to walk away informed, engaged, and equipped to share positively about MDPI.

About the Boston Summit

Held on 5–6 June, our first USA Summit gathered over 25 Chief Editors to learn more about MDPI’s activities and collaborations in the USA. The program included presentations, Q&A, and a panel discussion.

Agenda Highlights:

Moderated by Summer Huggard (Operations Manager [Toronto], MDPI), the program featured:

  • MDPI Overview and USA Collaboration – Stefan Tochev (CEO, MDPI)
  • AI in Publishing and MDPI's Actions – Feichi Lu (Junior Data Scientist, MDPI)
  • MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Panel Discussion – Stefan, Feichi, Giulia, Claudia
  • Society Partnerships – Dr. Clàudia Aunós (Society Partnerships Senior Manager, MDPI)
  • Voice of the Customer and Closing Remarks – Stefan Tochev (CEO, MDPI)

MDPI & the USA: Facts and Figures

  • With over 216,000 publications, the USA is MDPI’s second-largest contributor after China.
  • In 2024, the USA ranked 2nd in total submissions and 2nd in total MDPI publications, with more than 28,200 publications.
  • As of 2020, the cumulative number of authors from the USA until April 2025 was 352,099.
  • As at April 2025, there are more than 12,035 active Editorial Board Members (EBMs) from the USA, with 55% having an H-index over 26.
  • Among them, 96 serve as Editors-in-Chief (EiC) and 218 as section-Editors-in-Chief (SEiC)
  • MDPI has more than 920 Institutional Open Access Program agreements worldwide, with over 130 from the USA.

A special thanks to our Toronto team, and everyone who worked behind the scenes to make this event run smoothly.

Coming Together for Science

Highlights from the MDPI France Summit in Paris (12–13 June)

We completed our first MDPI France Summit in Paris last week, and it was a special event. Attendees were engaged from beginning to end, remaining after hours to network and collaborate.

Why a France Summit?

We chose to host a France Summit in view of the recent challenges MDPI has faced with the National Centre for Scientific Research (CNRS). What we took away from the event is that our authors and editors very much appreciate and enjoy working with us, but we need to address the concerns raised by CNRS, around Article Processing Charges (APCs) and the funding of gold open access publications.

“Our authors and editors very much enjoy working with us”

Some of the claims made in the June 2023 interview with Alain Schuhl, the Deputy CEO for Science at the CNRS, are simply not factual. For example, they state that MDPI’s “average APC charges per article are now around the same as Springer Nature’s.” Here is the relevant passage, reproduced verbatim:

This is not accurate.

A recent preprint analysing APC data from Elsevier, Springer Nature, Wiley, PLOS, MDPI, and Frontiers (2019–2023) shows that MDPI’s average APCs remain significantly lower than those of Springer Nature and several other major publishers.

The MDPI Summits are part of our outreach and communication efforts to address misconceptions and clarify MDPI’s position as one of the most accessible and affordable major gold open access publishers in the world.

Summit Overview

Held on 12–13 June, the France Summit gathered over 20 Chief Editors to learn more about MDPI’s activities and collaborations in France. Many of these editors are influential in their institutions and professional societies. Several also have connections to CNRS, which makes this an important opportunity to clarify how we operate and build trust through open and transparent communication and hopefully turn our editors into informed advocates of MDPI.

Summit Feedback

The feedback has been very positive, with most attendees completing the post-event survey and all rating the experience as Excellent or Good. A few highlights:

  • “The whole thing was highly professional and, above all, provided quantified details that will allow us to better answer questions surrounding MDPI.”
  • “The summit was an opportunity to meet personally various people directly engaged in the organization and policies of MDPI, which made it possible to clarify some important points concerning publishing with MDPI.”
  • “Very well organized! A great opportunity to see all French MDPI partners and editors.”

Program Highlights:

Moderated by Miruna Adelina Nicolcioiu (Senior Conference Producer), the program featured:

  • MDPI Overview and France Collaboration – Stefan Tochev (CEO)
  • MDPI Editorial Process and Peer-Review Quality – Dr. Marta Colomer (Public Affairs Specialist)
  • Institutional Partnerships and Open Access Funding Models – Becky Castellon (Institutional Partnerships Manager)
  • AI in Publishing and MDPI's Actions – Daniele Raimondi (Data Scientist)
  • Publication Ethics: Global Trends – Diana Cristina Apodaritei (Research Integrity Specialist)
  • Closing Remarks – Stefan Tochev
  • Panel Discussion – Diana, Becky, Prof. Dr. Patrick Da Cost, and Stefan

MDPI & France: Facts and Figures

  • With over 51,000 publications, France is MDPI's tenth-largest contributor, and fifth largest among EU countries after Italy, Spain, Germany, and Poland.
  • As of 2020, the cumulative number of authors from France until April 2025 was 87,592.
  • As at April 2025, there are more than 2,800 active Editorial Board Members (EBMs) from France, with 59% having an H-index over 26.
  • Among them, 22 serve as Editors-in-Chief (EiC) and 61 as section-Editors-in-Chief (SEiC)
  • In 2024, IJMS, JCM, and Molecules were the top three MDPI journals in terms of submissions from French-affiliated authors.

Special thanks to our colleagues from Romanian offices for organizing this successful event.

Closing Thoughts

Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award

As we wrap up this month’s newsletter, I’d like to take a moment to recognize the winners of the 2024 Tu Youyou Award, presented by our journal Molecules. I am pleased to share that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.

I invite you to read the editorial co-authored by the Tu Youyou Award Committee, which highlights the significance of the award and the remarkable impact of the recipients’ research.

A sincere thank-you to the 2024 Award Committee for their dedication and selection process, and congratulations once again to this year’s honourees. Your work exemplifies the kind of research MDPI is proud to support and amplify.

About the Tu Youyou Award
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honour the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award recognizing exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.

For further information about the award and the winners, please visit the Tu Youyou Award website.

Stefan Tochev
Chief Executive Officer
MDPI AG

26 June 2025
Cells Receives an Updated Impact Factor of 5.2


We are pleased to share that Cells (ISSN: 2073-4409) was awarded an increased Impact Factor of 5.2 in the 2024 Journal Citation ReportsTM released by ClarivateTM in June 2025. Cells ranks in Q2 (59 among 204 titles) in the “Cell Biology” category.

The 2024 Journal Impact Factor is calculated by dividing the number of citations received in 2024 to all publications in the journal from 2022 and 2023 by the total number of citable publications from those same years.

To learn more, visit our journal statistics website for detailed metrics or check out our news article for general information.

The support and dedication of all the editors, reviewers, authors, and readers are an integral part of the journal’s performance. We would like to take this opportunity to thank all of you who have contributed to the journal.

18 June 2025
Cells Receives an Increased CiteScore of 10.5


We are pleased to share that Cells (ISSN: 2073-4409) has received an increased CiteScore of 10.5 in June 2025. The CiteScore ranks the journal 27 out of 225 titles (Q1) in the “General Biochemistry, Genetics and Molecular Biology” category, an impressive achievement for a journal running in Volume 14.

You can find more statistics on our website.

The current CiteScores measure the average number of citations within a journal over a four-year window (2021–2024). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.

This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Cells and its growing impact in cell biology.

16 June 2025
Cells | Highly Downloaded Papers in 2023

Cells (ISSN: 2073-4409) is an international, peer-reviewed, open access journal published online semi-monthly by MDPI, providing an advanced forum for studies related to cell biology, molecular biology, and biophysics.

We are pleased to invite you to read the most highly downloaded papers of Cells in 2023.

  1. “A Beginner’s Guide to Cell Culture: Practical Advice for Preventing Needless Problems”
    by Sabine Weiskirchen, Sarah K. Schröder, Eva Miriam Buhl and Ralf Weiskirchen
    Cells 2023, 12(5), 682; https://doi.org/10.3390/cells12050682
    Available online: https://www.mdpi.com/2073-4409/12/5/682
  2. “A Review of Single-Cell RNA-Seq Annotation, Integration, and Cell–Cell Communication”
    by Changde Cheng, Wenan Chen, Hongjian Jin and Xiang Chen
    Cells 2023, 12(15), 1970; https://doi.org/10.3390/cells12151970
    Available online: https://www.mdpi.com/2073-4409/12/15/1970
  3. “The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders”
    by Emilija Knezevic, Katarina Nenic, Vladislav Milanovic and Nebojsa Nick Knezevic
    Cells 2023, 12(23), 2726; https://doi.org/10.3390/cells12232726
    Available online: https://www.mdpi.com/2073-4409/12/23/2726
  4. “Sirtuin 6—A Key Regulator of Hepatic Lipid Metabolism and Liver Health”
    by X. Charlie Dong
    Cells 2023, 12(4), 663; https://doi.org/10.3390/cells12040663
    Available online: https://www.mdpi.com/2073-4409/12/4/663
  5. “The “3Ds” of Growing Kidney Organoids: Advances in Nephron Development, Disease Modeling, and Drug Screening”
    by Brooke E. Chambers, Nicole E. Weaver and Rebecca A. Wingert
    Cells 2023, 12(4), 549; https://doi.org/10.3390/cells12040549
    Available online: https://www.mdpi.com/2073-4409/12/4/549
  6. “Flow Cytometry: The Next Revolution”
    by J. Paul Robinson, Raluca Ostafe, Sharath Narayana Iyengar, Bartek Rajwa and Rainer Fischer
    Cells 2023, 12(14), 1875; https://doi.org/10.3390/cells12141875
    Available online: https://www.mdpi.com/2073-4409/12/14/1875
  7. “Molecular Mechanisms in Autoimmune Thyroid Disease”
    by Hernando Vargas-Uricoechea
    Cells 2023, 12(6), 918; https://doi.org/10.3390/cells12060918
    Available online: https://www.mdpi.com/2073-4409/12/6/918
  8. “Spatial Transcriptomic Technologies”
    by Tsai-Ying Chen, Li You, Jose Angelito U. Hardillo and Miao-Ping Chien
    Cells 2023, 12(16), 2042; https://doi.org/10.3390/cells12162042
    Available online: https://www.mdpi.com/2073-4409/12/16/2042
  9. GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    by Ka Young Kim, Ki Young Shin and Keun-A Chang
    Cells 2023, 12(9), 1309; https://doi.org/10.3390/cells12091309
    Available online: https://www.mdpi.com/2073-4409/12/9/1309
  10. “In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation”
    by Yavor K. Bozhilov, Ian Hsu, Elizabeth J. Brownand Adam C. Wilkinson
    Cells 2023, 12(6), 896; https://doi.org/10.3390/cells12060896
    Available online: https://www.mdpi.com/2073-4409/12/6/896
  11. “CRISPR-Cas System: The Current and Emerging Translational Landscape”
    by Narendranath Bhokisham, Ethan Laudermilch, Lindsay L. Traeger, Tonya D. Bonilla, Mercedes Ruiz-Estevez and Jordan R. Becker
    Cells 2023, 12(8), 1103; https://doi.org/10.3390/cells12081103
    Available online: https://www.mdpi.com/2073-4409/12/8/1103
  12. “Recent Advances in CAR-Based Solid Tumor Immunotherapy”
    by Min Hwa Shin, Eunha Oh, Yunjeong Kim, Dae-Hwan Nam, So Young Jeon, Jin Hyuk Yu and Dohsik Minn
    Cells 2023, 12(12), 1606; https://doi.org/10.3390/cells12121606
    Available online: https://www.mdpi.com/2073-4409/12/12/1606
  13. “HIV–Host Cell Interactions”
    by Sepiso K. Masenga, Bislom C. Mweene, Emmanuel Luwaya, Lweendo Muchaili, Makondo Chona and Annet Kirabo
    Cells 2023, 12(10), 1351; https://doi.org/10.3390/cells12101351
    Available online: https://www.mdpi.com/2073-4409/12/10/1351
  14. “Current State and Future Directions in the Therapy of ALS”
    by Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt and Meret Herdick
    Cells 2023, 12(11), 1523; https://doi.org/10.3390/cells12111523
    Available online: https://www.mdpi.com/2073-4409/12/11/1523
  15. “Slowing the Progression of Diabetic Kidney Disease
    by Olivia Blazek and George L. Bakris
    Cells 2023, 12(15), 1975; https://doi.org/10.3390/cells12151975
    Available online: https://www.mdpi.com/2073-4409/12/15/1975
  16. “Liquid Biopsy in Neurological Diseases”
    by Sunny Malhotra, Mari Carmen Martín Miras, Agustín Pappolla, Xavier Montalban and Manuel Comabella
    Cells 2023, 12(14), 1911; https://doi.org/10.3390/cells12141911
    Available online: https://www.mdpi.com/2073-4409/12/14/1911
  17. “Current Strategies for Exosome Cargo Loading and Targeting Delivery”
    by Haifeng Zeng, Shaoshen Guo, Xuancheng Ren, Zhenkun Wu, Shuwen Liu and Xingang Yao
    Cells 2023, 12(10), 1416; https://doi.org/10.3390/cells12101416
    Available online: https://www.mdpi.com/2073-4409/12/10/1416
  18. “The Role of TP53 in Adaptation and Evolution”
    by Konstantinos Voskarides and Nefeli Giannopoulou
    Cells 2023, 12(3), 512; https://doi.org/10.3390/cells12030512
    Available online: https://www.mdpi.com/2073-4409/12/3/512
  19. “The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target”
    by William W. Feng, Hannah T. Zuppe and Manabu Kurokawa
    Cells 2023, 12(12), 1605; https://doi.org/10.3390/cells12121605
    Available online: https://www.mdpi.com/2073-4409/12/12/1605
  20. “Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation”
    by Flora Tassone, Dragana Protic, Emily Graves Allen, Alison D. Archibald, Anna Baud, Ted W. Brown, Dejan B. Budimirovic, Jonathan Cohen, Brett Dufour, Rachel Eiges et al.
    Cells 2023, 12(18), 2330; https://doi.org/10.3390/cells12182330
    Available online: https://www.mdpi.com/2073-4409/12/18/2330

More articles published in Cells can be accessed via https://www.mdpi.com/search?journal=cells.

3 June 2025
MDPI INSIGHTS: The CEO's Letter #23 - MDPI Summits Spain & Italy, Ei Compendex, and Editorial Independence

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Highlights from the MDPI Spain Summit in Barcelona (21-22 May)

In May we hosted the MDPI Spain Summit in Barcelona – our second summit in the city following the inaugural one in November 2023.


Stefan Tochev (CEO, MDPI) at the MDPI Spain Summit in Barcelona, 22 May 2025.

Creating a space for exchange of views

The goal of our summits is to bring together Chief Editors of MDPI journals from across disciplines and institutions. These intimate gatherings provide a platform to present the latest developments at MDPI and to initiate open conversations about our journals, the future of open access, and the evolving landscape of scientific publishing.

Most importantly, these are opportunities for in-person connection, providing a more meaningful space for the exchange of views and for building long-term relationships.

Exploring the future of scientific publishing in Spain

The summit took place on 21–22 May and featured a mix of MDPI presentations (including two guest presentations), roundtable discussions, and Q&A sessions. On the first day, we held a focused session with our Chief Editors to gather feedback and have open discussions on their journal development, the peer-review process, and local accreditation systems.


Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI, presents MDPI’s Editorial Process and Peer Review Quality Metrics at the MDPI Spain Summit in Barcelona, 22 May 2025.

I had the pleasure of opening the Summit with a welcome address and an overview of MDPI’s recent milestones. The agenda then included the following sessions:

  • MDPI and Recent Developments in the Spanish Market – Dr. Marta Colomer (Public Affairs Specialist, MDPI)
  • MDPI Editorial Process and Peer Review Quality Metrics – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Open Access in Spain – Dr. Remedios Melero (Researcher, CSIC – guest speaker)
  • AI in Publishing and MDPI's Actions – Dr. Enric Sayas (Business Analyst, MDPI), Daniele Raimondi (Data Scientist, MDPI), and Dr. Alexandre López-Borrull (Researcher, Universitat Oberta de Catalunya – guest speaker)
  • Publication Ethics – Ana Stankovic (Research Integrity and Publication Ethics, MDPI)
  • Opening and Closing remarks were provided by Rocksy Zhang (Editorial Director, MDPI)

We are extremely grateful for the strong engagement shown by our Editors, who were clearly appreciative of the event and the discussions we had. They felt seen and heard, which is a vital prerequisite for building open channels of communication and cultivating productive long-term collaborations.


MDPI colleagues during MDPI Spain Summit in Barcelona (22 May 2025).

A big thank-you to the entire Barcelona team for organizing such a successful event!

Upcoming MDPI Summit events:

  • Italy Summit – Rome (26–27 May)
  • US Summit – Boston, MA (5–6 June)
  • France Summit – Paris (12–13 June)
  • US Summit – Houston, TX (26–27 June)
  • UK Summit – London (16–17 September)
  • Germany Summit – Berlin (18–19 September)
  • Romania Summit – Bucharest (23–24 October)
    ...with more in between, and more to follow.

Impactful Research

50 MDPI Journals Now Indexed in Ei Compendex

Indexing is a key indicator of a journal’s scientific impact. An indexed journal gives research greater visibility and credibility within the global academic community and is recognized for its quality and relevance. While many of our journals are included in major databases such as Web of Science and Scopus, MDPI also places strong emphasis on journal inclusion in subject-specific indexing platforms that align with each journal’s scope. This ensures that when you publish with MDPI, you publish with impact.

I’m pleased to share that as at May 2025, 51 of our journals are now indexed in Ei Compendex, a leading bibliographic database for engineering and applied sciences. This is a major milestone that reflects both the quality or our editorial processes and the relevance of the research we publish in these fields.

“When you publish with MDPI, you publish with impact”

Discoverability and reach

Inclusion in Ei Compendex means greater discoverability for our authors and broader reach of our journals in the fields of engineering and technology. It improves our ability to support global research and innovation, while building MDPI’s reputation in the applied sciences. This recognition is the result of the dedicated work of our editorial teams, reviewers, and authors, and of our overall commitment to excellence in publishing.

You can read our full announcement here.

Appreciative thanks to everyone involved in reaching this milestone.

Inside MDPI

 

One Year of MDPI’s Seoul Office

On 29 April, we marked one year since the opening of our Seoul office, MDPI’s first local hub in South Korea. South Korea is a key market for MDPI, currently ranking as our sixth-largest contributor to the company’s total publications, with over 89,000 MDPI articles authored by individuals affiliated with Korean institutions. Over the past 12 months, the Seoul team has made great strides in building our visibility, networks, and presence in the region.

A few highlights from the past year


Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, is the Office Manager of the Seoul office.

In its inaugural year, the Seoul office focused primarily on marketing and promotional activities to support the MDPI brand locally. During that time, the team concentrated on scholar visits to local institutions, attending academic conferences, and hosting editorial board meetings.

The team also secured 10 Institutional Open Access Program (IOAP) renewals, signed three new IOAP agreements, and established one new Society affiliation.

The Seoul office also hosted its first library book fair and reached over 1,000 followers on its LinkedIn channel, which is an encouraging indication of local visibility and engagement.

“The Seoul team has made strides in building our visibility, networks, and presence in the region”

Growth plans

Later this year, we are working on opening a new Seoul office in a more central location, with room for our growing team. The new space will bring us closer to other publishing partners and provide easier access to and from the airport. The Seoul office will continue to expand its efforts in outreach and engagement as its builds its presence in South Korea.

Warm thanks to the entire Seoul team for their hard work and dedication, and to all MDPI colleagues who have contributed to this exciting chapter in our global journey.

Coming Together for Science

Highlights from the MDPI Italy Summit in Rome (26–27 May)

We closed the month of May by hosting the first MDPI Italy Summit in Rome. This was an important event for us, as Italy has consistently ranked among the top ten countries globally for open access publications over the past decade.

MDPI and Italy: Facts & Figures

  • With over 144,000 publications (as at 31 May 2025), Italy is MDPI’s third largest contributor after China and the USA.
  • In 2024, MDPI was the second-largest publishing house in Italy.
  • The 7,165 Editorial Board Members (EBMs) drawn from Italian institutions represent 8.9% of all MDPI academic editors.
  • Among these, 319 serve as Editors-in-Chief (EiCs) or Section Editors-in-Chief (SEiCs).
  • Eleven Italian EBMs were recognized as 2024 Clarivate Highly Cited Researchers.
  • In 2024, MDPI received 24,873 review reports and collaborated with 88,578 reviewers from Italy.
  • 23,131 Guest Editors from Italian institutions led 4,827 Special Issues across 248 MDPI journals.
  • MDPI partners with over 900 institutions globally, of which 17 are in Italy.

The MDPI Italy Summit in Rome


Dr. Prof. Giulio Cerullo, EiC of Applied Sciences, at the MDPI Italy Summit in Rome (27 May 2025).

Held on 26–27 May, the MDPI Italy Summit brought together 25 Chief Editors from across our journal portfolio, including some of our largest journals such as Applied Sciences, to discuss MDPI’s latest developments and collaborations in the Italian market, our use of data intelligence and AI to support strategic decision-making, a look into our editorial process, peer-review quality metrics, and conversations around research integrity and community engagement.

The Summit featured MDPI presentations followed by Q&A and concluded with a roundtable discussion. On the evening of the 26th, we hosted a dinner with our Editors to connect personally, learn more about their research, and hear feedback on journal operations and the broader academic landscape in Italy.


Gathering of Editors-in-Chief and MDPI staff at the MDPI Italy Summit in Rome (27 May 2025).

Event Agenda – 27 May

Moderated by Maddalena Favaretto (Conference Scientific Advisor, MDPI), the program featured:

  • MDPI Overview, Achievements, Latest News and Future Developments – Stefan Tochev (CEO, MDPI)
  • Country Report: Italy – Dr. Laura Perez Martin (Conference Assistant, MDPI)
  • AI in Publishing and MDPI’s Actions – Dr. Andrea Perlato (Head of Data Analytics, MDPI)
  • MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Panel Discussion – Stefan, Andrea, Giulia


Panel Discussion with Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI), Dr. Andrea Perlato (Head of Data Analytics, MDPI) during the MDPI Italy Summit in Rome (27 May 2025).

A big thank-you to our Conference team and everyone who worked behind the scenes to make these events run smoothly.

Closing Thoughts

Upholding Editorial Independence in Scholarly Publishing

A recent MDPI blog post written by Dr. Ioana Craciun (Scientific Communications Specialist, MDPI), “Editorial Independence and Publisher Support: Collaborating to Uphold Integrity,” highlights the important balance between editorial autonomy and publisher collaboration in academic publishing.

As the leading fully Open Access scholarly publisher, we are proud to champion editorial independence within our publishing process.

Drawing from the Committee on Publication Ethics (COPE) guidelines, the article emphasizes that while editors must have the freedom to make decisions based on scholarly merit, publishers play a critical role in providing the necessary infrastructure and tools to support the editorial process. This collaborative approach ensures the integrity of the peer review process, builds trust among authors and readers, and upholds the quality and relevance of published content.

MDPI highlights its commitment to this model by investing in research integrity specialists, AI tools for plagiarism detection, and administrative support, all aimed at empowering editors to make independent, informed decisions.

Stefan Tochev
Chief Executive Officer
MDPI AG

20 May 2025
Meet Us at the 56th Symposium of the Polish Society of Histochemists and Cytochemists, 28–31 May 2025, Olsztyn, Poland


Conference: The 56th Symposium of the Polish Society of Histochemists and Cytochemists
Organizer: Polish Society of Histochemists and Cytochemists
Date: 28–31 May 2025
Place: Hotel Anders, ul. Spacerowa 2, 14-133 Stare Jabłonki, Poland

MDPI journals will be exhibitors at PHTC 2025, which will be held in Olsztyn, Poland, from 28 to 31 May 2025.

The 56th Symposium, titled “From the Silver to Dream—Histochemistry is Good for Everything,” is organized by the Olsztyn Branch of the Polish Society of Histhoms and Cytochemists.

The following MDPI journals will be represented:

If you will be attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://pthc2025.pl/.

13 May 2025
Empowering Academic Growth with MDPI: A Scientific Publishing Exchange at Toronto Metropolitan University, 15 May 2025


MDPI is excited to collaborate with Toronto Metropolitan University to host an engaging Scientific Publishing Workshop aimed at empowering scholars with the knowledge and tools needed to succeed in academic publishing. This workshop will delve into the key aspects of MDPI’s open access publishing framework, offering an in-depth exploration of journal selection, the editorial workflow, and the essentials of publication ethics. Participants will also gain practical advice on improving their scientific writing and effectively addressing reviewer comments, with guidance from an experienced professional. This session promises to equip attendees with valuable skills to elevate their publishing journey.

Workshop Highlights:

  • Learn How to Better Write and Structure a Research Article;
  • How to Choose Where to Publish Academic Work;
  • How to Respond to Reviewer Comments;
  • Reasons for Rejection During Pre-Check;
  • How to Navigate Through Ethics and AI Use.

Date: 15 May 2025
Time: 12:00–1:30 p.m.
Venue: Toronto Metropolitan University

Program:

Speakers

Program and Content

Time

Dr. Stephen Mora

Introduction to MDPI

12:00–12:05 p.m.

 

How to Write and Structure a Research Article

12:05–12:45 p.m.

 

How to Respond to Reviewer Comments

12:45–1:30 p.m.

Dr. Stephen Mora has an M.Sc. and Ph.D. in kinesiology and health science from York University, Canada. He started working at MDPI in May 2024 and is now the Managing Editor of IJOM, a newly transferred society journal published by MDPI. During his graduate studies and MDPI tenure, Stephen has gained extensive experience in attending conferences, meeting with scholars, and hosting online and in-person presentations.

7 May 2025
Cells Exceptional Reviewers List 2025


We are thrilled to share the updated Exceptional Reviewers List 2025. This program was designed to recognize and honor scholars who have delivered consistently exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Cells (ISSN: 2073-4409) recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. We thank our pool of excellent reviewers.

We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in Cells’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable.

The Exceptional Reviewers List was introduced in May 2025. Each quarter, we will be selecting a group of outstanding reviewers and introducing them here.

Q4

Name: Dr. Mark A. Eiteman
Affiliation: School of Chemical, Materials and Biomedical Engineering, College of Engineering, University of Georgia, Athens, GA, USA
Name: Dr. Benjamin Roche
Affiliation: Columbia Rd, Stop 9037 Grand Forks, ND 58202, USA
Name: Dr. Joon W. Shim
Affiliation: Department of Biomedical Engineering, College of Engineering and Computer Sciences (CECS), Marshall University, Huntington, WV 25755, USA
Name: Dr. Gyorgy Lur
Affiliation: Department of Neurobiology and Behavior, University of California, Irvine, CA, USA
 
Name: Dr. Dario Melgari
Affiliation: IMTC – Institute of Molecular and Translational Cardiology,
San Donato Milanese
 
Name: Dr. Elke Albrecht
Affiliation: Research Institute of Farm Animal Biology (FBN), WG Muscle-Fat-Crosstalk, Wilhelm-Stahl-Allee 2, D-18196 Dummerstorf, Germany
Name: Dr. Ivana Grkovic
Affiliation: Department of Molecular Biology and Endocrinology, VINČA Institute of Nuclear Sciences, University of Belgrade, Belgrade, Serbia
Name: Dr. Thomas Falguières
Affiliation: UMR_S 1193 Inserm / Université Paris-Saclay, Bâtiment Henri Moissan - HM1, 3ème étage - Bureau 3818, 17, avenue des sciences, 91400 Orsay, France
 
Name: Dr. Eugenia V. Gurevich
Affiliation: Department of Pharmacology, Vanderbilt University, USA
Name: Dr. Christopher S. Von Bartheld
Affiliation: University of Nevada, Reno, USA
Name: Dr. Amedeo Vetere
Affiliation: Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
Name: Dr. Tahereh Mina Derakhshan
Affiliation: Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, USA
Name: Dr. Claes Wahlestedt
Affiliation: Center for Therapeutic Innovation, Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA
Name: Dr. Giovanna Petrucci
Affiliation: Fondazione Policlinico Universitario Agostino Gemelli IRCCS., Rome, Italy
Name: Dr. Maaike Kockx
Affiliation: Atherosclerosis Laboratory, ANZAC Research Institute, Concord Repatriation General Hospital and University of Sydney, Sydney, Australia
 
Name: Dr. Fernando Revert
Affiliation: Research Group in Molecular and Mitochondrial Medicine, Catholic University of Valencia 'San Vicente Mártir', 46001 Valencia, Spain
 
Name: Dr. Jacqueline Heger
Affiliation: Institute of Physiology, Justus Liebig University, 35392 Giessen, Germany
Name: Dr. Davina Camargo Madeira Simoes
Affiliation: Faculty of Science and Environment, Northumbria University,
Newcastle upon Tyne NE18ST, UK
Name: Dr. Sonja Forss-Petter
Affiliation: Medizinische Universitat Wien, Vienna, Austria
Name: Dr. Vikas Yadav
Affiliation: Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, 20213 Malmö, Sweden
Name: Dr. Beatrice Radu
Affiliation: Faculty of Biology, Department of Anatomy, Animal Physiology and Biophysics, University of Bucharest, Bucharest, Romania
Name: Dr. Yuexuan Chen
Affiliation: University of Rochester Medical Center: Rochester, New York, USA
 
Name: Dr. Patrícia Faísca
Affiliation: BioISI—Instituto de Biossistemas e Ciências Integrativas, Departamento de Física, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal
Name: Dr. Akira Kitamura
Affiliation: Laboratory of Molecular Cell Dynamics, Faculty of Advanced Life Science, Hokkaido University, N21W11, Kita-ku, Sapporo, Hokkaido 001-0021, Japan
Name: Dr. Petra Grbčić
Affiliation: Department of Microbiology and Parasitology, University of Rijeka, Faculty of Medicine, Braće Branchetta 20, 51000 Rijeka, Croatia
Name: Dr. Hao-ai Shui
Affiliation: Graduate Institute of Medical Science, National Defense Medical Center, Taipei 114201, Taiwan
Name: Dr. Maria Laura Bacci
Affiliation: Department of Veterinary Medical Sciences, University of Bologna, 40064 Ozzano dell’Emilia (BO), Italy
Name: Dr. Corey L. Campbell
Affiliation: Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, 80523, USA
Name: Dr. Albert Smolenski
Affiliation: UCD School of Medicine, UCD Conway Institute, University College Dublin, Dublin, Ireland
Name: Dr. Yordan Sbirkov
Affiliation: Department of Medical Biology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria

See what our reviewers say about the review process of Cells:

The clear website organization made the reviewing process efficient and easy to conduct. The scoring categories are clear and constitute a good complement to the review text.”—Dr. Benjamin Roche

Reviewing for Cells has been a great experience so far. It’s always nice to receive good papers to review and to see them being eventually published after revision.”—Dr. Dario Melgari

When I review for MDPI, I appreciate the support of editorial office members, the fast response to questions and competent help.”—Dr. Elke Albrecht

I strive to deliver the types of review that I would hope to receive for my own manuscripts—ones that help to improve their quality and make them easier to read.”—Dr. Christopher S. Von Bartheld

Reviewing for Cells has been a rewarding experience. I value the journal’s rigorous standards, efficient editorial process, and commitment to constructive scientific dialogue.”—Dr. Davina Camargo Madeira Simoes

Experienced peer reviewer in anti-cancer drug discovery, cardiovascular disease and endothelial biology, genomics, in silico approaches, and WNT signaling”—Dr. Vikas Yadav

The review process at Cells is efficient and well‑organized. The editorial office provides timely reminders that help prevent unnecessary delays, and authors are given sufficient time to revise their manuscripts. Overall, the process shows the journal’s author‑friendly workflow.”—Dr. Hao-ai Shui

The process was very smooth and efficient, the communication between all sides was quick and in the end led to a considerably improved manuscript, which is the main point of the whole process.”—Dr. Yordan Sbirkov

Q3

Name: Dr. Adam J. Wolpaw
Affiliation: University of Pennsylvania Perelman School of Medicine, Philadelphia, United States
 
Name: Dr. Oleksii Skorokhod
Affiliation: Department of Life Sciences and Systems Biology, University of Torino, 10123 Torin, Italy
 
Name: Dr. Tadahide Izumi
Affiliation: Graduate Center for Toxicology, University of Kentucky College of Medicine, 306 Health Sciences Research Building, Lexington, KY 40536-0305, USA
 
Name: Dr. Aleksandra Suchanecka
Affiliation: Independent Laboratory of Behavioral Genetics and Epigenetics, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 St., 70-111 Szczecin, Poland
 
Name: Dr. Shashi Shekhar Singh
Affiliation: Case Western Reserve University, School of Medicine, Department of Biochemistry,2109 Adelbert Rd, Cleveland, OH 44106, USA
 
Name: Dr. Seung-Hyun Jeong
Affiliation: College of Pharmacy, Sunchon National University, 255 Jungang-ro, Suncheon-si 57922, Jeollanam-do, Republic of Korea
 
Name: Dr. Bogdan Jakiela
Affiliation: Uniwersytet Jagielloński Collegium Medicum, Krakow, Poland
Name: Dr. Aikaterini Ntemka
Affiliation: Aristotle University of Thessaloniki, Faculty of Health Sciences, School of Veterinary Medicine
Name: Dr. Zhongwu Zhou
Affiliation: Department of Cardiovascular & Metabolic Science, Lerner Research Institute at Cleveland Clinic, Cleveland, OH 44106, USA
Name: Dr. Katalin Szászi
Affiliation: Keenan Research Centre for Biomedical Science of the St. Michael’s Hospital and Department of Surgery, University of Toronto, Toronto, ON M5B 1W8, Canada
Name: Dr. Holly Voges
Affiliation: Murdoch Children’s Research Institute, Melbourne, Australia
Name: Dr. Karol Rycerz
Affiliation: Department of Animal Anatomy and Histology, Faculty of Veterinary Medicine, University of Life Sciences, Akademicka 12, Lublin, 20-033, Poland
Name: Dr. Parijat Sil
Affiliation: Princeton University, USA
Name: Dr. Gunter Schmidtke
Affiliation: Division of Immunology, Department of Biology, University of Konstanz, D-78457 Konstanz, Germany.
Name: Dr. Mohamed Hamed
Affiliation: School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA
Name: Dr. Alessandra Norris
Affiliation: Vanderbilt University, Nashville, USA
 
Name: Dr. Yasuhiro Kosuge
Affiliation: Laboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan
Name: Dr. Jayna Mistry
Affiliation: The Jackson Laboratory, USA
Name: Dr. Alireza Shoari
Affiliation: Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA
Name: Dr. Klaus Fortschegger
Affiliation: St. Anna Children’s Cancer Research Institute (CCRI), 1090 Vienna, Austria
Name: Dr. Juan Carlos Tapia
Affiliation: Harvard University, USA
Name: Dr. Susmita Barman
Affiliation: Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Name: Dr. Koraljka Husnjak
Affiliation: Goethe University Medical School, D-60590 Frankfurt am Main, Germany
Name: Dr. Gergely Róna
Affiliation: Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA
 
Name: Dr. Vinita Chittoor
Affiliation: University of California, San Francisco, USA
Name: Dr. Ivan Nagaev
Affiliation: Department of Clinical Microbiology Doctor of Philosophy, Umeå University, Sweden
Name: Dr. Nelly Olova
Affiliation: Institute of Ecology and Evolution, School of Biological Sciences, University of Edinburgh, UK
Name: Dr. Laurent Grossin
Affiliation: Université de Lorraine, France
Name: Dr. Suzanne De La Monte
Affiliation: Departments of Pathology and Laboratory Medicine, Neurology, and Neurosurgery, Rhode Island Hospital, Women & Infants Hospital, Brown University Health, Alpert Medical School of Brown University, Providence, RI 02912, USA
Name: Dr. Vasileios Leivaditis
Affiliation: Department of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, Germany
 

See what our reviewers say about the review process of Cells:

Reviewing helped me remain always updated and critically engaged with current developments in my scientific field.”—Dr. Oleksii Skorokhod

Serving as a reviewer for Cells has been an enriching experience, promoting clarity, rigor, and innovation in scientific publications.”— Dr. Shashi Shekhar Singh

It’s an honor to be recognized. From learning to review with my PhD mentor, Dr. Kopinke, to now as a postdoc, I strive to approach each review with respect and curiosity.”— Dr. Alessandra Norris

I am deeply honored to have contributed to a process that balances scholarly rigor with rapid publication, and this recognition will greatly encourage my future research activities.”— Dr. Yasuhiro Kosuge

Serving as a reviewer is a privilege. I strive to provide timely, constructive, and rigorous feedback that helps authors strengthen their science while improving clarity, rigor, and reproducibility.”—Dr. Alireza Shoari

It’s been a rewarding experience contributing to Cells by critically evaluating innovative research and supporting authors in strengthening scientific rigor and translational relevance.”—Dr. Susmita Barman

Q2

Name: Prof.Dr. Francis William Luscinskas
Affiliation: Harvard Medical School
NRB, Room 752P
77 Avenue Louis Pasteur, Boston, MA 2115, USA
Name: Dr. Matthias Nees
Affiliations: 1 Department of Biochemistry and Molecular Biology, Medical University in Lublin, ul. Chodzki 1, 20-093 Lublin, Poland;
2 Institute of Biomedicine and Western Cancer Centre FICAN West, University of Turku, 20101 Turku, Finland
Name: Prof. Dr. Maria Quetglas-Llabrés
Affiliation: Health Research Institute of Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
Name: Dr. Amber Mills
Affiliation: University of Pittsburgh, USA
Name: Dr. Kim Keeling
Affiliation: Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States
Name: Dr. Hengrui Liu
Affiliation: The University of Cambridge, UK
Name: Prof. Dr. Justin C. Konje
Affiliation: Department of Health Sciences, University of Leicester, Leicester LE1 7RH, UK
Name: Dr. Shizue Mito
Affiliation: Department of Medical Education, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX 78541, USA
Name: Dr. Victor Manuel González Suárez
Affiliation: Department of Electrical Engineering, University of Oviedo, Gijón 33204, Spain
Name: Prof. Dr. Anna Silvia Pistocchi
Affiliation: Università degli Studi di Milano, Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Via Viotti, 3/5, 20133, Milano, Italy
Name: Prof.Dr. Ken-ichi Sato
Affiliation: Department of Molecular Biosciences, Faculty of Life Sciences, Kyoto Sangyo University, Kamigamo-Motoyama, Kita-ku, Kyoto, Japan
Name: Dr. Quentin Lemaire
Affiliation: Univ. Lille, CNRS, UMR 8576—UGSF—Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France
Name: Dr. Jason Stumhofer
Affiliation: University of Arkansas for Medical Sciences, USA
Name: Dr. Roberta Palmour
Affiliation: Department of Human Genetics, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 0C7, Canada
Name: Dr. Anthony Pedley
Affiliation: Department of Biochemistry and Molecular Biology Carver College of Medicine, The University of Iowa, USA
Name: Dr. Yangluowa Qu
Affiliation: Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA
Name: Dr. Valentyn Oksenych
Affiliation: University of Bergen, 5020 Bergen, Norway
Name: Dr. Gaskon Ibarretxe
Affiliation: University of the Basque Country (UPVEHU)
Faculty of Medicine and Nursing
Cell Biology and Histology Department
Barrio Sarriena sn, 48940, Leioa, Spain
Name: Dr. Timothy Keiffer
Affiliation: LSU Health Shreveport, USA
Name: Prof. Dr. Hitoshi Sawada
Affiliations: 1 Professor, Department of Food and Life Environment, College of Human Life and Environment, Kinjo Gakuin University, Moriyama-ku, Nagoya, Japan;
2 Emeritus Professor, Nagoya University, chikusa-ku, Nagoya, Japan
Name: Dr. Jens Schuster
Affiliation: Uppsala Universitet, Uppsala, Sweden
Name: Dr. Paulina Tokarz
Affiliation: Department of Molecular Genetics, Faculty of Biology and Environmental Protection, The University of Lodz, Łódź, Poland
Name: Prof. Dr. Lucie Germain
Affiliation: Department of Surgery, Faculty of Medicine, Université Laval, Québec, QC G1V 0A6, Canada. Regenerative Medicine Division, CHU de Québec—Université Laval Research Centre, Québec, QC G1J 1Z4, Canada Université Laval Research Center on Experimental Organogenesis/LOEX, Québec, QC G1J 1Z4, Canada
Name: Dr. Lenka Stixova
Affiliation: Academy of Sciences of the Czech Republic, Department of Molecular Cytology and Cytometry, Prague, Czech Republic
Name: Dr. Gerasimos Daras
Affiliation: Agricultural University of Athens, Department of Biotechnology, Athens, Greece
Name: Prof. Dr. Rita Payan-Carreira
Affiliation: Department of Veterinary Medicine, School of Sciences and Technology, and CHRC-Comprehensive Health Research Centre, University of Évora, Portugal
Name: Dr. Carlos Rossa Junior
Affiliation: Universidade Estadual Paulista “Júlio de Mesquita Filho”, Sao Paulo, Brazil
Name: Dr. Nerea Cuesta-Gomez
Affiliation: Alberta Diabetes Institute, Edmonton, Canada
Name: Dr. Yohannes Woubishet Woldeamanuel
Affiliation: Mayo Clinic Arizona; Ex-Amplify Therapeutics, USA
Name: Dr. John Woulfe
Affiliation: L’Hôpital d’Ottawa, Ottawa, Canada

See what our reviewers say about the review process of Cells:

I work in the Cell Biology and Histology Department of EHU in Spain. I would not say I am a particularly harsh reviewer. When I perceive an honest, well-minded effort on the part of authors to address the concerns involved, provided there are not particularly serious methodological or conceptual issues, I usually give them a chance to get their manuscript published.”—Dr. Gaskon Ibarretxe

It was a pleasure to evaluate Cells articles.”—Prof. Dr. Lucie Germain

Engaging in review processes stimulates my curiosity about cellular and physiological mechanisms while keeping me current with emerging developments and methodological advances in my field of expertise.”—Prof. Dr. Rita Payan-Carreira

Reviewing is a way to uphold the quality and integrity of science, while staying engaged with the latest discoveries and supporting fellow researchers in the field. I appreciate the opportunity and look forward to continuing to contribute to Cells.”—Dr. Nerea Cuesta-Gomez

I am honored to be recognized by Cells for my peer-review contributions. Reviewing cutting-edge research in circadian medicine and biomarkers is rewarding, and I am committed to advancing scientific rigor.”—Dr. Yohannes Woubishet Woldeamanuel

Read more testimonials at https://www.mdpi.com/testimonials?type=all&journal_id=32&page_count=20.

Q1

Name: Dr. Wei Wen Lim
Affiliation: National Heart Research Institute Singapore, National Heart Centre Singapore, 169609, Singapore
Name: Prof. Dr. Jae-Wook Oh
Affiliation: Department of Stem Cell and Regenerative Biotechnology, KIT, Konkuk University, Seoul, Republic of Korea
Name: Dr. Giovanna Liguori
Affiliation: Institute of Genetics and Biophysics Adriano Buzzati Traverso, Naples, Italy
Name: Dr. Yoichi Ezura
Affiliation: Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan
Name: Dr. Bruno Brando
Affiliation: Hematology Laboratory and Transfusion Center, Legnano General Hospital, 20025 Legnano (Milano), Italy
Name: Dr. Benoit Miotto
Affiliation: Team Epigenetics and Nuclear Functions in Human Diseases, Université Paris Cité, Institut Cochin, INSERM U1016, CNRS UMR8104, F-75014 Paris, France
Name: Dr. Yongqing Liu
Affiliation: Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, KY, USA
Name: Dr. Tomaž Büdefeld
Affiliation: Centre for Human Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia
Name: Dr. Cláudia Saraiva
Affiliation: INSERM-Université Bourgogne U1231, Equipe GAD Génétique des Anomalies du Développement, Dijon, France
Name: Prof. Dr. Gundula Schulze-Tanzil
Affiliation: Institute of Anatomy and Cell Biology, Paracelsus Medical University, Nuremberg and Salzburg, 90419 Nuremberg, Germany
Name: Dr. Abhishek Tyagi
Affiliation: Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
Name: Dr. Riya Thomas
Affiliation: Seattle Children’s Research Institute, 1900 9th Ave, Seattle, WA 98101, USA
Name: Prof. Dr. Mirko Manetti
Affiliation: Department of Experimental and Clinical Medicine, Section of Anatomy and Histology, University of Florence, Florence, Italy
Name: Prof. Dr. Giuseppe Biagini
Affiliation: Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41100 Modena, Italy
Name: Dr. Wenjing Zhang
Affiliation: Department of Pathology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA
Name: Dr. Mary Gilbert
Affiliation: Office of Research and Development, Center for Public Health and Environmental Assessment, US Environmental Protection Agency, Research Triangle Park, NC 27709, USA
Name: Dr. Sudeep Kumar
Affiliation: Cincinnati Children’s Hospital Medical Center 3333 Burnet Ave Cincinnati, OH 45229, USA
Name: Dr. Christine Hellweg
Affiliation: Department of Radiation Biology, Institute of Aerospace Medicine, German Aerospace Center (DLR), 51147 Cologne, Germany
Name: Dr. Ignacio Torrecilla
Affiliation: Department of Oncology, University of Oxford: Oxford, Oxfordshire, UK
Name: Prof. Dr. Margaret L. Britz
Affiliation: Tasmanian Institute of Agriculture, University of Tasmania, Hobart, TAS 7005, Australia
Name: Dr. Sarath Babu Nukala
Affiliation: Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Name: Dr. Jezabel Rodriguez-Blanco
Affiliation: Darby Children’s Research Institute, Hollings Cancer Center, Medical University of South Carolina, Miami, USA
Name: Dr. Phillip Domeier
Affiliation: Department of Microbiology and Immunology, University of British Columbia: Vancouver, British Columbia, Canada
Name: Dr. Jose Rodriguez-Alvarez
Affiliation: Department Bioquímica i Biologia Molecular, Institut de Neurociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain
Name: Dr. Michał Zarobkiewicz
Affiliation: Department of Clinical Immunology, Medical University of Lublin, Lublin, Poland
Name: Dr. Béla Papp
Affiliation: Institut National de la Santé et de la Recherche Médicale, Inserm UMR 1342, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Paris, France
Name: Dr. Kristina Pilipović
Affiliation: Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Name: Prof. Dr. Johannes Boltze
Affiliation: School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK
Name: Dr. Harinarayanan Janakiraman
Affiliation: Michael DeBakey Department of Surgery, Baylor College of Medicine, Houston TX 77030, USA
Name: Dr. Qing Jun Wang
Affiliation: College of Medicine, University of Kentucky, Lexington, KY 40536, USA

See what our reviewers say about the review process of Cells:

The review process is well organized and straightforward. The professional editorial team provides tremendous support, making it a good experience for reviewers and authors alike.”—Prof. Dr. Johannes Boltze

In the era of AI-powered generators, the revision undertaken by independent reviewers based on their prior work experience and accumulated knowledge is paramount to ensure the sustained flourishing of the research community.”—Dr. Tomaž Büdefeld

As a retired senior academic, I have the time and experience to add value to the peer-review processes. It is a duty that requires considerable effort, to spot the gems as well as the glitches, by thorough analysis of data and checking all claims based on data and the literature cited. It is also a two-way conversation aimed at improving the submitted manuscripts so that any resulting publication enriches our knowledge through accurate reporting. I gain a lot out of this and hope my well-meant feedback adds value.”—Prof. Dr. Margaret L. Britz

Reviewing for Cells is guided by a comfortable platform: Cells addresses emerging fields. Hence, I benefit by updating my scientific point of view and I feel that my comments are generally addressed.”—Prof. Dr. Gundula Schulze-Tanzil

6 May 2025
Meet Us at the Chinese Society of Plant Physiology and Plant Molecular Biology 2025 Annual Meeting, 28 July–1 August 2025, Heilongjiang, China


Conference: Chinese Society of Plant Physiology and Plant Molecular Biology 2025 Annual Meeting
Organization: Chinese Society of Plant Biology
Date: 28 July–01 August 2025
Place: Heilongjiang, China

MDPI journals will be present as exhibitors at the Chinese Society of Plant Physiology and Plant Molecular Biology 2025 Annual Meeting, which will be held at the Sheraton Harbin Xiangfang Hotel, Heilongjiang, China, from 28 July to 1 August 2025.

This conference will cover the following topics:

  1. Plant metabolism and nutritional health;
  2. Plant development and cell fate;
  3. Plant carbon sink and physiological ecology;
  4. Phytoremediation biology and sustainable agriculture;
  5. Plant adversity perception and trait plasticity;
  6. Plant–microbe symbiosis and nutrition;
  7. Crop molecular design breeding;
  8. Plant–biotic interactions and crop disease and pest resistance;
  9. Plant epigenetics;
  10. Interdisciplinary forum;
  11. Young scholars forum;
  12. Youth forum on natural product biosynthesis;
  13. Young scholars’ growth and journal development forum.

The following MDPI journals will be represented:

If you will be attending this conference, please feel free to visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

Back to TopTop